Treatments for contaminant reduction in lactoferrin preparations and lactoferrin-containing compositions
View Patent ↗A method of preparing an ultra-cleansed lactoferrin preparation, termed treatment for contaminant reduction (TCR) is provided which includes the steps of treating commercial lactoferrin preparation with at least one each of surfactants, antioxidants and polyphenols to form purified lactoferrin (LF-TCR) and drying the LF-TCR. Additionally a therapeutic lactoferrin composition is provided which contains LF-TCR and optionally surfactants, antioxidants, polyphenols, tissue/membrane diffusion facilitating agents and anionic compounds. The therapeutic lactoferrin composition can additionally contain bioactive agents, dietary supplements, nutraceuticals/functional foods, prophylactic agents, therapeutic agents and probiotic lactic acid bacteria.
1. A therapeutic lactoferrin composition comprising:
lactoferrin purified by the method of treatment for contaminant reduction (LF-TCR), said method comprising the steps of:
1) treating said commercial lactoferrin preparation with at least one surfactant;
2) contacting said surfactant-treated lactoferrin with at least one antioxidant;
3) purifying said antioxidant-treated lactoferrin with at least one polyphenol to form purified lactoferrin; and
4) diving said purified lactoferrin;
said therapeutic composition further comprising at least one surfactant;
at least one antioxidant;
at least one polyphenol; and
at least one anionic compound;
wherein microbial load and endotoxin activity in said lactoferrin have been eliminated.
2. The therapeutic lactoferrin composition of claim 1 wherein said at least one surfactant is selected from the group consisting of food-grade detergents, bile salts and plant saponins.
3. The therapeutic lactoferrin composition of claim 1 wherein said at least one antioxidant is selected from the group consisting of Vitamin A, Vitamin C, Vitamin E and metal chelators.
4. The therapeutic lactoferrin composition of claim 1 wherein said at least one polyphenol is selected from the group consisting of oleoresins, terpenes, flavonoids and biliproteins.
5. The therapeutic lactoferrin composition of claim 1 wherein said at least one anionic compound is selected from the group consisting of carbonates, bicarbonates or carbonated liquids.
6. The therapeutic lactoferrin composition of claim 1 wherein the daily dosage of lactoferrin is between approximately 0.01 and 10,000.00 mg.
7. The therapeutic lactoferrin composition of claim 1 wherein said therapeutic lactoferrin composition is delivered to a tissue/mucosal site of a recipient in need thereof.
8. The therapeutic lactoferrin composition of claim 7 wherein said tissue/mucosal site is selected from the group consisting of the gastrointestinal tract, the oropharyngeal region, the nasopharyngeal region, the vulvo-vaginal region and the skin.
9. The therapeutic lactoferrin composition of claim 1 wherein said therapeutic lactoferrin composition comprises a pharmaceutical formulation selected from the group consisting of tablets, capsules, powders, drinks, chewable tablets, mouthwashes, suppositories, douches, ointments, skin cleansing solutions, crèmes, makeup, antiperspirants and shampoos.
10. A therapeutic lactoferrin composition comprising:
lactoferrin purified by the method of treatment for contaminant reduction (LF-TCR) wherein microbial load and endotoxin activity in said lactoferrin have been eliminated said method comprising the steps of:
1) treating said commercial lactoferrin preparation with at least one surfactant;
2) contacting said surfactant-treated lactoferrin with at least one antioxidant;
3) purifying said antioxidant-treated lactoferrin with at least one polyphenol to form purified lactoferrin; and
4) drying said purified lactoferrin.